Determination of furosemide in whole blood using SPE and GC-EI-MS

Journal of Analytical Toxicology

Volumn 29, Issue 5, 2005, Pages 309-313

  Margalho, Claudia ^a   De Boer, Douwe ^b   Gallardo, Eugenia ^c   Barroso, Mário ^a   Vieira, Duarte Nuno ^a  

^a INSTITUTO NACIONAL DE MEDICINA LEGAL E CIÊNCIAS FORENSES   (Portugal)

^b Instituto Nacional do Desporto   (Portugal)

^c Instituto de Medicina Legal   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; KETOPROFEN;

ACCURACY; ANALYTIC METHOD; AUTOPSY; BLOOD ANALYSIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG DETERMINATION; FORENSIC MEDICINE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; SOLID PHASE EXTRACTION; STATISTICAL ANALYSIS;

EID: 23944485168     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.5.309     Document Type: Conference Paper

References (23)

1. H.J.E.M. Reeuwijk, U.R. Tjaden, and J. Van der Greef. Simultaneous determination of furosemide and amiloride in plasma using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 575: 269-274 (1992).
2. A.K. Singh, C. McArdle, M. Sshhraf, K. Granley, U. Mishra, and B. Gordon. Evaluation of high performance liquid chromatography (HPLC), enzyme linked immunosorbent assay (ELISA), particle concentration fluorescence immunoassay (PCFIA), methods for the screening, quantitation and pharmacokinetic study of furosemide in horses. Forensic Sci. Int. 47: 1-15 (1990).
3. H.R. Jacobson and J.P. Kokko. Diuretics: sites and mechanisms of action. Annu. Rev. Pharmacol. Toxicol. 16: 201-214 (1976).
4. J. Flórez. Farmacología Humana. 3rd ed. Masson S.A, Barcelona, Spain, 1997.
5. W. Osswald and S. Guimarães. Terapêutica Medicamentosa e suas Bases Farmacológicas: Manual de Farmacologia e Farmacoterapia, 4th ed. Porto Editora, Porto, Portugal, 2001.
6. R. Ventura and J. Segura. Detection of diuretic agents in doping control. J. Chromatogr. B 687: 127-144 (1996).
7. M. Hammarlund-Udenaes and L.Z. Benet. Furosamide pharmacokinetics and pharmacodynamics in health and disease-an update). Pharmacokinet. Biopharm. 17: 1-46 (1989).
8. J. Caslavska and W. Thormann. Rapid analysis of furosemide in human urine by capillary electrophoresis with laser-induced fluorescence and electrospray ionisation-ion trap mass spectrometric detection. J. Chromatogr. B 770: 207-216 (2002).
9. Clarke's Analysis of Drugs and Poisons, 3rd ed., A.C. Moffat, M.D. Osselton, and B. Widdop, Eds. Pharmaceutical Press, London, U.K., 2004, part two, pp 1068-1069.
10. F.G.M. Russel, Y. Tan, J.J.M. Van Meijel, F.W.J. Gribnau, and C.A.M. Van Ginneken. Solid-phase extraction of furosemide from plasma and urine and subsequent analysis by high-performance liquid chromatography. J. Chromatogr. 496: 234-241 (1989).
11. The International Association of Forensic Toxicologists. TIAFT net-Therapeutic and Toxic Drug Concentrations List, http://www.tiaft.org/ tmembers/ttv/ttv_el.html, 〈July 2004〉 accessed July 2004.
12. World Anti-Doping Agency. The World antidoping code-the 2004 Prohibited List International Standard, http://www.wada-ama.org/en/t1.asp, 〈March 2004〉 accessed July 2004.
13. C.Y. Gradeen, D.M. Billay, and S.C. Chan. Analysis of bumetanide in human urine by high-performance liquid chromatography with fluorescence detection and gas chromatography/mass spectrometry. J. Anal. Toxicol. 14: 123-126 (1990).
14. S.-J. Park, H.-S. Pyo, Y.-J. Kim, M.-S. Kim, and J. Park. Systematic analysis of diuretic doping agents by HPLC screening and GC/MS confirmation. J. Anal. Toxicol. 14: 84-89 (1990).
15. B. Lindström and M. Molander. Gas chromatographic determination of furosemide in plasma using na extractive alkylation technique and an electron capture detector. J. Chromatogr. 101: 219-221 (1974).
16. E.T. Lin, D.E. Smith, L.Z. Benet, and B.-A. Hoener. High-performance liquid chromatographic assays for furosemide in plasma and urine. J. Chromatogr. 163: 315-221 (1979).
17. M. Saugy and P. Meuwly. Rapid high-performance liquid chromatographic determination with fluorescence detection of furosemide in human body fluids and its confirmation by gas chromatography-mass spectrometry. J. Chromatogr. 564: 567-578 (1991).
18. J. Segura, R. Ventura, and C. Jurado. Derivatization procedures for gas chromatography-mass spectrometry of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J. Chromatogr. B 713: 61-90 (1998).
19. H.H. Maurer. Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. J. Chromatogr. B 733: 3-25 (1999).
20. D. Thieme, J. Grosse, R. Lang, R.K. Mueller, and A. Wahl. Screening, confirmation and quantitation of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionisation tandem mass spectrometry. J. Chromatogr. B 757: 49-57 (2001).
21. D. Carreras, C. Imaz, R. Navajas, M.A. Garcia, C. Rodríguez, A.F. Rodríguez, and R Cortes. Comparison of derivatization procedures for the determination of diuretics in urine by gas chromatography-mass spectrometry. J. Chromatogr. A 683: 195-202 (1994).
22. International Conference on Harmonization (ICH). Validation of Analytical Procedures: Methodology, ICH Q2B, http://www. eudra.org/emea.html, accessed June 2003.
23. F.T. Peters and H.H. Maurer. Bioanalytical method validation and its implications for forensic and clinical toxicology - a review. Accredit. Qual. Assur. 7: 441-449 (2002).